Literature DB >> 9713667

Post-exposure prophylaxis for HIV infection in gay and bisexual men. Implications for the future of HIV prevention.

S C Kalichman1.   

Abstract

OBJECTIVE: To assess the psychological and behavioral characteristics of gay and bisexual men who intend to use antiretroviral post-exposure prophylaxis (PEP) to prevent HIV infection.
METHODS: Gay and bisexual men who had not tested HIV seropositive and were not in long-term exclusive sexual relationships (n = 327) completed anonymous surveys consisting of demographic characteristics, gay community acculturation, experience with and attitudes toward PEP, substance use, and sexual behavior in the past 6 months.
SETTING: A large annual Gay Pride festival in Atlanta, Georgia.
RESULTS: There were 8 (3%) men who had already used PEP and 85 (26%) who planned to use PEP to prevent themselves from becoming HIV infected. Compared to the 242 (74%) men who did not indicate plans to use PEP, those planning to use PEP were younger, less well educated, more likely to have used illicit substances in the past 6 months, and were more likely to have a history of injection drug use. Men intending to use PEP were also more likely to have practiced unprotected anal and oral intercourse as the receptive partner and were more likely to have multiple anal intercourse partners with whom they were receptive.
CONCLUSIONS: Gay and bisexual men are generally supportive of the immediate use of PEP and a significant number of men are planning to use PEP, particularly less educated men who use multiple substances and practice the highest-risk sexual behaviors. Concurrent behavioral interventions must, therefore, be considered critical in the advancement of PEP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9713667     DOI: 10.1016/s0749-3797(98)00037-3

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  13 in total

Review 1.  Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies.

Authors:  Lisa A Eaton; Seth Kalichman
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

Review 2.  Treatment to prevent transmission of HIV-1.

Authors:  Myron S Cohen; Cynthia L Gay
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 3.  Are we headed for a resurgence of the HIV epidemic among men who have sex with men?

Authors:  R J Wolitski; R O Valdiserri; P H Denning; W C Levine
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

4.  A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.

Authors:  Lisa A Eaton; Derrick D Matthews; Daniel D Driffin; Leigh Bukowski; Patrick A Wilson; Ron D Stall
Journal:  Prev Sci       Date:  2017-07

5.  HIV transmission risk among HIV seroconcordant and serodiscordant couples: dyadic processes of partner selection.

Authors:  Lisa A Eaton; Tessa V West; David A Kenny; Seth C Kalichman
Journal:  AIDS Behav       Date:  2008-10-25

6.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

7.  Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis.

Authors:  Cynthia L Gay; Myron S Cohen
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

8.  Psychometric analysis of the Life Worries Scale for a new generation of sexual minority men: The P18 Cohort Study.

Authors:  Perry N Halkitis; Stephanie H Cook; Annie Ristuccia; James Despotoulis; Michael D Levy; Francesca C Bates; Farzana Kapadia
Journal:  Health Psychol       Date:  2017-10-02       Impact factor: 4.267

Review 9.  Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?

Authors:  Wenya Yu; Lu Wang; Na Han; Xiayan Zhang; Tanmay Mahapatra; Sanchita Mahapatra; Giridhar R Babu; Weiming Tang; Roger Detels; Jinkou Zhao
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-07-31       Impact factor: 5.678

10.  Attitudes toward Web application supporting pharmacist-clinician comanagement of postexposure prophylaxis patients.

Authors:  Crystal M Fuller; Alezandria K Turner; Diana Hernández; Alexis V Rivera; Silvia Amesty; Michael D Lewis; Stuart Feldman
Journal:  J Am Pharm Assoc (2003)       Date:  2013 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.